These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 28597936)

  • 1. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins.
    Colca JR; McDonald WG; Cavey GS; Cole SL; Holewa DD; Brightwell-Conrad AS; Wolfe CL; Wheeler JS; Coulter KR; Kilkuskie PM; Gracheva E; Korshunova Y; Trusgnich M; Karr R; Wiley SE; Divakaruni AS; Murphy AN; Vigueira PA; Finck BN; Kletzien RF
    PLoS One; 2013; 8(5):e61551. PubMed ID: 23690925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the Mitochondrial Pyruvate Carrier by Tolylfluanid.
    Chen Y; McCommis KS; Ferguson D; Hall AM; Harris CA; Finck BN
    Endocrinology; 2018 Feb; 159(2):609-621. PubMed ID: 29126303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione.
    Chen Z; Vigueira PA; Chambers KT; Hall AM; Mitra MS; Qi N; McDonald WG; Colca JR; Kletzien RF; Finck BN
    J Biol Chem; 2012 Jul; 287(28):23537-48. PubMed ID: 22621923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice.
    Wu D; Eeda V; Undi RB; Mann S; Stout M; Lim HY; Wang W
    Mol Metab; 2021 Dec; 54():101363. PubMed ID: 34710641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese mice.
    de Mendonça M; de Sousa É; da Paixão AO; Araújo Dos Santos B; Roveratti Spagnol A; Murata GM; Araújo HN; Imamura de Lima T; Passos Simões Fróes Guimarães DS; Silveira LR; Rodrigues AC
    Mol Cell Endocrinol; 2020 Feb; 501():110661. PubMed ID: 31770568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial pyruvate carrier 2 hypomorphism in mice leads to defects in glucose-stimulated insulin secretion.
    Vigueira PA; McCommis KS; Schweitzer GG; Remedi MS; Chambers KT; Fu X; McDonald WG; Cole SL; Colca JR; Kletzien RF; Burgess SC; Finck BN
    Cell Rep; 2014 Jun; 7(6):2042-2053. PubMed ID: 24910426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss.
    Fukunaga T; Zou W; Rohatgi N; Colca JR; Teitelbaum SL
    J Bone Miner Res; 2015 Mar; 30(3):481-8. PubMed ID: 25257948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis.
    McCommis KS; Hodges WT; Brunt EM; Nalbantoglu I; McDonald WG; Holley C; Fujiwara H; Schaffer JE; Colca JR; Finck BN
    Hepatology; 2017 May; 65(5):1543-1556. PubMed ID: 28027586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier.
    Divakaruni AS; Wiley SE; Rogers GW; Andreyev AY; Petrosyan S; Loviscach M; Wall EA; Yadava N; Heuck AP; Ferrick DA; Henry RR; McDonald WG; Colca JR; Simon MI; Ciaraldi TP; Murphy AN
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5422-7. PubMed ID: 23513224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones.
    Benova A; Ferencakova M; Bardova K; Funda J; Prochazka J; Spoutil F; Cajka T; Dzubanova M; Balcaen T; Kerckhofs G; Willekens W; van Lenthe GH; Alquicer G; Pecinova A; Mracek T; Horakova O; Rossmeisl M; Kopecky J; Tencerova M
    Mol Metab; 2022 Nov; 65():101598. PubMed ID: 36103974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPC1-like Is a Placental Mammal-specific Mitochondrial Pyruvate Carrier Subunit Expressed in Postmeiotic Male Germ Cells.
    Vanderperre B; Cermakova K; Escoffier J; Kaba M; Bender T; Nef S; Martinou JC
    J Biol Chem; 2016 Aug; 291(32):16448-61. PubMed ID: 27317664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.
    Higashi Y; Holder K; Delafontaine P
    J Biol Chem; 2010 Nov; 285(47):36361-8. PubMed ID: 20843793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice.
    Fukui Y; Masui S; Osada S; Umesono K; Motojima K
    Diabetes; 2000 May; 49(5):759-67. PubMed ID: 10905484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of inducible 6-phosphofructo-2-kinase impairs the suppressive effect of PPARγ activation on diet-induced intestine inflammatory response.
    Guo X; Li H; Xu H; Halim V; Thomas LN; Woo SL; Huo Y; Chen YE; Sturino JM; Wu C
    J Nutr Biochem; 2013 May; 24(5):770-5. PubMed ID: 22841546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones.
    Lu M; Sarruf DA; Talukdar S; Sharma S; Li P; Bandyopadhyay G; Nalbandian S; Fan W; Gayen JR; Mahata SK; Webster NJ; Schwartz MW; Olefsky JM
    Nat Med; 2011 May; 17(5):618-22. PubMed ID: 21532596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages.
    Nguyen MT; Chen A; Lu WJ; Fan W; Li PP; Oh DY; Patsouris D
    PLoS One; 2012; 7(4):e34976. PubMed ID: 22529965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization.
    Wang QA; Zhang F; Jiang L; Ye R; An Y; Shao M; Tao C; Gupta RK; Scherer PE
    Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29483301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.